Verition Fund Management LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2023$442,515
-10.0%
10,663
+30.5%
0.01%
-14.3%
Q1 2023$491,524
+105.7%
8,173
+156.4%
0.01%
+250.0%
Q4 2021$239,000
-33.8%
3,188
+96.1%
0.00%
-33.3%
Q2 2021$361,000
-32.6%
1,626
-82.0%
0.00%
-83.3%
Q2 2020$536,000
+75.7%
9,034
+149.6%
0.02%
+200.0%
Q4 2019$305,000
-1.6%
3,619
-12.6%
0.01%
-33.3%
Q3 2019$310,0000.0%4,140
-35.7%
0.01%
-25.0%
Q1 2019$310,0006,4360.01%
Other shareholders
NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders